Skip to main content
. 2015 Sep 15;6:197. doi: 10.3389/fphar.2015.00197

FIGURE 3.

FIGURE 3

Passive targeting is enabled by ‘leaky’ vessels with fenestrae up to several 100 nm in tumor-associated endothelium and a poor lymphatic drainage, increasing both likelihood and retention time of nano-sized particles in the interstitium (EPR effect). After extravasation, NB/particles could also actively target specific surface molecules on cancer cells (schematic illustration, not drawn to scale).